SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 19th, 2024 • Allarity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of January 18, 2024, between Allarity Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SENIOR CONVERTIBLE NOTE DUE January 18, 2025Allarity Therapeutics, Inc. • January 19th, 2024 • Pharmaceutical preparations • Delaware
THIS SENIOR CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Senior Convertible Notes of Allarity Therapeutics, Inc., a Delaware corporation (the “Company”), having its principal place of business at 24 School Street, 2nd Floor, Boston, MA 02108, designated as its Senior Convertible Note due January 18, 2025 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
